Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects

NCT01437592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: insulin degludec

Sponsor

Novo Nordisk A/S